Vident Investment Advisory, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$1,160,000
+11.5%
5,927
-3.1%
0.06%
+5.5%
Q2 2020$1,040,000
-42.0%
6,118
-70.8%
0.06%
-65.0%
Q3 2019$1,792,000
+22.8%
20,976
-0.5%
0.16%
+34.2%
Q2 2019$1,459,000
-21.4%
21,084
-16.8%
0.12%
+17.0%
Q1 2019$1,856,000
+26.0%
25,343
-2.5%
0.10%
+20.5%
Q4 2018$1,473,000
+289.7%
25,993
+682.7%
0.08%
+80.4%
Q4 2016$378,0003,3210.05%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,365,840,00020.68%
Lagoda Investment Management, L.P. 398,529$20,620,0007.88%
Matrix Capital Management Company, LP 2,118,000$109,585,0003.72%
Ghost Tree Capital, LLC 300,000$15,522,0003.23%
Sio Capital Management, LLC 100,000$5,174,0002.46%
GREAT POINT PARTNERS LLC 249,500$12,909,0002.31%
Redmile Group, LLC 665,139$34,414,0002.10%
Eventide Asset Management 525,000$27,164,0001.69%
Opus Point Partners Management, LLC 35,093$1,816,0001.66%
Boxer Capital, LLC 125,000$6,468,0001.54%
View complete list of SEATTLE GENETICS INC shareholders